Author/Editor | Zupanič-Pajnič, Irena | |
Title | Molekularno genetska identifikacija skeletnih ostankov | |
Translated title | Molecular genetic identification of skeletal remains | |
Type | članek | |
Vol. and No. | Letnik 52, št. 2 | |
Publication year | 2013 | |
Volume | str. 213-234 | |
ISSN | 0353-3484 - Medicinski razgledi | |
Language | slv | |
Abstract | 330a Histamine receptor type 3 was discovered in 1983 by Schwartz and coworkers and cloned in 1999. The expression ofhistamine receptor type 3 is largely confined to the central nervous system, where differential transcriptional and posttranscriptional processing lead to a high degree of molecular and functional heterogeneity. Histamine receptor type 3 has unique properties including constitutive activity in viva and the recruitment of plasticity-related signal transduction pathways, including Gai/0 - proteins, adenylyl cyclase, phospholipase Az, mitogen-activated protein kinase and Akt/glycogen synthase kinase 3 signalling. These make the histamine receptor type 3 the most prominent target for histaminergic drug development. Histamine receptor type 3 can function both as an auto receptor and as a heteroreceptor. As an autoreceptor on histaminergic neurons, histamine receptor type 3 activation inhibits celi firing, histamine synthesis and release. As a presynaptic heteroreceptors on other neurons, histamine receptors type 3 abundantly control the outf1ow of various neurotransmitters, including biogenic amines, acetylcholine, glutamate and y-amino butyric acid. The histamine receptor type 3 functioning is associated with cognition, behaviour, wakefulness and sleep regulation, locomotion, appetite regulation and pa in perception. | |
Keywords | skeletal remains short tandem repeat mitochondrial DNA skeletni ostanki kratke tandemske ponovitve mitohondrijska DNA |